In the dynamic landscape of healthcare, actively engaging patients in chronic condition management is pivotal. For those battling Inflammatory Bowel Disease (IBD), the transformative power of self-testing and health tracking through apps like "MyIBDCare" is a game-changer. This innovative approach empowers patients to take self-control, promoting oversight and granting improved outcomes.
In the dynamic landscape of healthcare, actively engaging patients in chronic condition management is pivotal. For those battling Inflammatory Bowel Disease (IBD), the transformative power of self-testing and health tracking through apps like "MyIBDCare" is a game-changer. This innovative approach empowers patients to take self-control, promoting oversight and granting improved outcomes.
Inflammatory Bowel Disease, comprising Crohn's disease and ulcerative colitis, is a chronic condition that demands vigilant management. Frequent flare-ups and fluctuations in disease activity can significantly impact an individual's quality of life. Until recently, patients relied heavily on in-person appointments with healthcare providers, often resulting in delays in detecting changes in their condition.
Empowering patients in IBD management involves utilizing portable testing devices for at-home monitoring of key health parameters. This includes measuring Calprotectin levels, a gold standard biomarker for IBD, and capturing Subjective Patient Feedback through the "MyIBDCare" app. This approach provides valuable insights, promoting a proactive approach to health.
Empowering patients in IBD management involves utilizing portable testing devices for at-home monitoring of key health parameters. This includes measuring Calprotectin levels, a gold standard biomarker for IBD, and capturing Subjective Patient Feedback through the "MyIBDCare" app. This approach provides valuable insights, promoting a proactive approach to health.
The collaboration between Ampersand and Calpro, with the integration of CalproSmart into MyIBDCare, marks a significant leap in IBD management. This collaboration enhances patient autonomy and provides clinicians with a more accurate view of disease progression. It alleviates the administrative burden on healthcare professionals, ensuring responsive support for those with IBD. As self-testing and health-tracking apps continue to evolve, they will undoubtedly shape a future where IBD management prioritizes patient empowerment, early intervention, and improved outcomes.
Allowing the patients to participate to a greater extent in their disease management requires that the patient is equipped with monitoring tools that enable physicians to provide accurate follow-ups.
Want to know more about the Calprotectin Solutions suited for distant monitoring? Get the advantage of our expertise - contact us today!
Ankersen DV et al., E-Health and remote management of patients with inflammatory bowel disease: lessons from Denmark in a time of need. Intern Med J. 2021.
Burisch J et al., Telemonitoring and self-care in patients with IBD. In: RK Cross and AR Watson, eds. Telemanagement of Inflammatory Bowel Disease. Springer US; 2015.
De Jong MJ, et al., Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017.
De Jong MJ, et al., Costeffectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial. Clin Gastroenterol Hepatol. 2020.
Pang L, et al., Role of Telemedicinein Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Med Internet Res. 2022.